select trial glp 1 GLP-1s are not just a weight loss story. The newest research points to something bigger: whole-body protection. Heart, kidneys, joints, sleep, and inflammation are all showing up in the data. Here is What the SELECT trial of

Digestive Issues Women with Lipedema already have higher rates of: IBS Constipation Bloating SIBO (small intestinal bacterial overgrowth) Slow digestion GLP-1s slow gastric emptying even further, which can increase: Constipation Gastroparesis Reflux Nausea If digestive issues are present, they ideally should be addressed before starting GLP-1s

Naltrexone is not a controlled substance, is not habit-forming, and does not produce a euphoric effect

Ongoing medical monitoring helps catch any weight regain early when it's easier to address

This assessment helps identify those factors and provides guidance to support lasting success

doi:10.1002/oby.24027 41